Sepsis Assessment in Belgian Emergency Rooms (SABER)
Prospective, Non-interventional, Multi-centre Clinical Study to Assess the Clinical Validity of the Heparin Binding Protein Assay to Assist in Evaluation of Patients With Suspected Infection Following Emergency Department Admission
Sponsor: Axis Shield Diagnostics Ltd
Terminated
Resource constraints at participating sites
A observational or N/A phase clinical study on Sepsis and Severe Sepsis, this trial is terminated or withdrawn. The trial is conducted by Axis Shield Diagnostics Ltd and has accumulated 13 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Terminated
-
Sep 2024 — Sep 2025 [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Dec 2021 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Dec 2021 [monthly]
Terminated
▶ Show 8 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Terminated
-
Feb 2019 — Nov 2020 [monthly]
Terminated
Status: Suspended → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Suspended
-
May 2018 — Jun 2018 [monthly]
Suspended
-
Apr 2018 — May 2018 [monthly]
Suspended
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Suspended NA
-
Jul 2017 — Aug 2017 [monthly]
Suspended NA
Status: Recruiting → Suspended
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Axis Shield Diagnostics Ltd
For direct contact, visit the study record on ClinicalTrials.gov .